to Content
Header Image

01: From basic research to economic value

-
Hauptschule
Breakout / Working Group
english language

In today s economic world knowledge, especially technological and scientific knowledge is becoming the most important factor for the success of an economy. Universities and research institutions are producers and owners of this knowledge, parts of which have to be patented and protected. In an institution dedicated to excellent basic research, the financial exploitation of intellectual property must be secondary to the main goal of the organisation. On the other hand, a modern university or research institution has to take care to market the resulting intellectual property rights as ‘by-products’ of basic research in a professional way, thus deriving another source of income for basic research and thus contribute to the economy. By discussing three topics – (i) Improving technology transfer, (ii) Are conflicts of interest between basic research and technology transfer unavoidable? (iii) Start-ups from academic research institutions – we will try to provide the participants with expert knowledge from the daily practice.

Austrian Federal Minister for Education, Vienna
Senior Associate Provost and Chief Technology Development Officer, Office of Technology Development, Harvard University, Cambridge
Director of Technology Transfer, The Tech Transfer Unit, University of Copenhagen
Senior Patent & Licensing Manager Life Sciences, Max-Planck-Innovation GmbH, Munich
Member of the French Academy of Sciences; Director General, PALUMED, Labège
CEO & President, Femtolasers Produktions GmbH, Wien
Nobelpreisträger für Physik; Professor emeritus, Institut für Festkörperforschung, Forschungszentrum Jülich GmbH, Jülich
Professor Emeritus, Department of Biological Chemistry and Former Vice President for Technology Transfer, Weizmann Institute of Science, Rehovot
Head of Corporate Technology Central Eastern Europe (CEE), Siemens AG Österreich, Vienna

Dr. Sonja HAMMERSCHMID

Austrian Federal Minister for Education, Vienna

Promotion zum Doktor der Naturwissenschaften (Medizinische Genetik) Wissenschaftliche Mitarbeiterin, Boehringer Ingelheim Austria GmbH Wissenschaftliche Mitarbeiterin, Universität Wien (Postdoc) Produktmanagerin bei Margaritella-Biotrade GmbH Leiterin von Life Science Austria bei der Innovationsagentur GmbH (seit 2003 aws) Investmentmanagerin der UniVenture Fonds Geschäftsführerin, ARGE LISA Vienna Region Leiterin des Bereichs Technologie & Innovation und Gesamtprokuristin (seit 2003) in der Austria Wirtschaftsservice GmbH (aws) Geschäftsführerin der ARGE Impulsprogramm Creativwirtschaft Stellvertretende Vorsitzende, Universitätsrat Veterinärmedizinische Universität Wien Aufsichtsrätin Innovacell Biotechnologie AG Rektorin, Veterinärmedizinische Universität Wien Aufsichtsrätin Vetwidi Forschungsholding GmbH Aufsichtsratsvorsitzende Kunsthalle Wien GmbH
1995
1990-1995
1995-1997
1998-1999
1999-2005
2000-2010
2002-2005
2003-2010
2004-2006
2008-2010
2009-2010
2010-2016
seit 2010
seit 2011

LL.B MBA Isaac T. KOHLBERG

Senior Associate Provost and Chief Technology Development Officer, Office of Technology Development, Harvard University, Cambridge

Tel Aviv University School of Law, Tel Aviv, Israel, LL.B. University of Strasbourg, France, Diploma for French Cultural and Historical Studies INSEAD - Institut Europeen d'Administration aux Affaires, Fountainbleau, France, M.B.A. Mennen Medical Company Ltd., Tel Aviv, Israel, Marketing Manager Weizmann Institute of Science, Rehovot, Israel. Managing Director, YEDA Research & Development Co. Ltd.. Led the technology transfer program at the Weizmann Institute of Science where he negotiated multiple joint venture and royalty deals which continue to pay dividends in the multi-million dollar range Vice President for Industrial Liaison, New York University Medical Center. Established and led the office of Science and Technology Administration at NYU School of Medicine, with responsibility for sponsored programs, research administration, clinical trials and technology transfer New York University, NY Associate Dean, Science and Technology Administration, NYU Medical Center Vice Provost, Vice Dean, Industrial Liaison and Research Administration, NYU School of Medicine Established and led the technology transfer program at New York University, NYU School of Medicine and its affiliated hospitals; established and led NYU School of Medicine s Clinical Trials Development program and guided NYU's participation in and served on the Board of the Biomedical Research Alliance of New York. Tel Aviv University, Israel. Chief Executive Officer, Ramot and the Economic Corporation reorganized the technology licensing operation, Ramot, at Tel Aviv University. Hired new senior staff managing a total of 28 and recruited the board, made up predominately of industrialists and venture capitalists, to whom Ramot reports. Established and led the Economic Corporation at Tel Aviv University to oversee the revenue generation centers of the University including real estate and technology transfer and the newly formed functions of publishing and E-learning.
1979
1980
1981
1982
1986-1989
1989-1998
1989-2001
1994-1998
1999-2001
2001-2005

Karen LAIGAARD

Director of Technology Transfer, The Tech Transfer Unit, University of Copenhagen

Teaching Assistant, University of Aalborg, Denmark Project Co-ordinator, University of Strathclyde, Glasgow, United Kingdom Marketing Manager, The British Council Scotland, Glasgow, United Kingdom International Marketing Manager, Research and Enterprise, University of Glasgow, United Kingdom Head of Section, Danish Ministry of Science, Technology and Innovation, Copenhagen, Denmark Director of Technology Transfer, University of Copenhagen
1990-1992
1992-1993
1993-1996
1996-2001
2002-2003
since 2003

Dr. Egenhard LINK

Senior Patent & Licensing Manager Life Sciences, Max-Planck-Innovation GmbH, Munich

 After his final exams in Biology at the Technical University and Ludwig Maximilians University in Munich, Germany, Egenhard Link accomplished his diploma thesis at the Max Planck Institute of Biochemistry in Martinsried. For his Ph.D. and as a Postdoc he conducted research in the Boyer Center for Molecular Medicine, Howard Hughes Medical Institute, at Yale University in New Haven, Connecticut (USA). Among other things, he elucidated the mechanisms of action of tetanus and botulinum neurotoxins.
 After five years in the United States he returned to Germany to become research associate at the Max Planck Institute for Experimental Medicine in Goettingen and to build up the small albeit profitable start-up company Synaptic Systems. In fall 2000, Egenhard Link joined Max Planck Innovation where he holds the position of Senior Patent and Licensing Manager and is responsible for Technology Transfer of Max Planck Institutes in the field of 'Life Sciences'

Ph.D. Bernard MEUNIER

Member of the French Academy of Sciences; Director General, PALUMED, Labège

Researcher, Centre National de la Recherche Scientifique, France (CNRS) Associate Professor at the Ecole Polytechnique, Palaiseau, France President of the Centre National de la Recherche Scientifique, France (CNRS) Founder of PALUMED S.A. (4 VC's investors)
1973-2006
1993-2006
2004-2006
2000

Dipl.-Ing. Andreas STINGL

CEO & President, Femtolasers Produktions GmbH, Wien

Masters degree in electrial engineering at the Vienna University of Technology Co-founder and general manager of 'Stingl OEG', Korneuburg Co-founder, CEO and President of 'Femtolasers Produktions GmbH', Vienna
1992
1994
1997

Dr. Dr. h.c. mult. Peter Andreas GRÜNBERG

Nobelpreisträger für Physik; Professor emeritus, Institut für Festkörperforschung, Forschungszentrum Jülich GmbH, Jülich

Studies of physics at Johann Wolfgang Goethe-Universität University in Frankfurt am Main, Germany, intermediate diploma 1962 Continues studies of physics at Darmstadt University of Technology, Germany, diploma 1966, doctor's degree 1969 Postdoctoral Fellow of National Research Council of Canada at Carleton University in Ottawa, Canada Research scientist at the Institute of Solid State Research at Forschungszentrum Jülich, Germany Habilitation at the University of Cologne, Germany, "Privatdozent" Research stay at Argonne National Laboratory, Illinois, USA Activities in the field of antiferromagnetic coupling in Fe/Cr/Fe layers Work on the GMR effect in Jülich, Germany Appointment as adjunct professor at the University of Cologne, Germany Six-month research stay at the University of Sendai and at Tsukuba Research Centre, Japan After 32 years at Jülich, Germany, Peter Grünberg retires, but continues working
1959-1963
1963-1969
1969-1972
since 1972
1984
1984-1985
1986
1988
1992
1998
2004

Ph.D. David MIRELMAN

Professor Emeritus, Department of Biological Chemistry and Former Vice President for Technology Transfer, Weizmann Institute of Science, Rehovot

M.Sc. Polymer Chemistry, Hebrew University, Jerusalem Ph.D. Biochemistry of Bacterial Cell Walls, Weizmann Institute of Science, Rehovot, Israel Post Doctorate, Tufts University Medical School, Boston, USA Faculty Member, Department of Biological Chemistry, Weizmann Institute of Science Visiting Scientist, Max-Planck-Institute, Tuebingen Associate Professor with tenure University of California, Berkeley Harvard University, Cambridge, MA Full Professor, Weizmann Institute Besen-Brender Chair of Microbiology and Parasitology, Department of Biological Chemistry, Weizmann Institute of Science Fogarty Scholar, National Institutes of Health, Bethesda, MD Chairman of the Board of Directors, Yeda Research and Development Co. Ltd. Member Board of Directors, News Datacom Corp., Jerusalem, Israel Member Board of Directors, Weizmann Technological Incubator Company Vice President for Technology Transfer, Weizmann Institute of Science Member of Board of Directors, XTL Biotechnology, Rehovot, Israel Member of Board of Directors of Portman Pharmaceuticals, Rehovot, Israel Dean, Faculty of Biochemistry, Weizmann Institute of Science President, Israel Society for Microbiology President of Scientific Council, Conseil I.Pasteur-Weizmann I.
 *1938 - Buenos Aires, Argentina, Immigrated to Israel 1949
1964
1968
1968-1970
since 1970
1973
1976
1976-1977
1984
1984
1985
1991-1992
1987-1998
1989-1992
1991-1994
1993-1998
1995-1998
1996-1998
1999-2004
1999-2001
2004-2012

Dipl.-Ing. Dr. Gerald MURAUER

Head of Corporate Technology Central Eastern Europe (CEE), Siemens AG Österreich, Vienna

TU Wien Wirtschaftsingenieurwesen, Dipl.-Ing. Industrie-Finanzierung Industrielle Betriebswirtschaftslehre Material Science Studium TU Wien Wirtschaftsingenieurwesen, Dr. Dissertation: Unternehmensgründungen durch Venture Capital Berater, Boston Consulting Group Stv. Geschäftsführer, Wiener Wissenschafts- und Technologiefonds Unternehmersgründer, Murauer & Partner
1994-1999
1999-2001
2001-2002
2002-2005
2005-2007

Technology Forum

show timetable
Kategorie: all Breakout Plenary Social

21.08.2008

08:00 - 10:30 Technology brunch hosted by Tiroler Zukunftsstiftung Social
11:00 - 11:20 Opening by the European Forum Alpbach Plenary
11:20 - 12:00 Plenary session Plenary
12:00 - 12:30 Plenary session Plenary
13:00 - 13:45 Ethics of science Plenary
13:45 - 14:30 Stem cells Plenary
15:00 - 16:00 Politics and science – Advice through science Plenary
18:00 - 19:30 Bionics Plenary
19:30 - 21:30 Reception hosted by Alcatel-Lucent Austria AG Social

22.08.2008

07:00 - 14:00 Working Group 07: Success factor human resources – Regions in competition Breakout
07:00 - 14:00 Working Group 01: From basic research to economic value Breakout
07:00 - 14:00 Working Group 09: The governance of applied research: responsibilities, independence and resources Breakout
07:00 - 14:00 Working Group 03: The myths of life sciences and their consequences Breakout
07:00 - 13:00 Ö1 Children’s University Alpbach – Science and technology for kids Breakout
07:00 - 14:00 Working Group 05: Think Tanks in Austria Breakout
07:00 - 14:00 Working Group 06: Gender mainstreaming in science and development. Perceive realities and decide visionarily Breakout
07:00 - 14:00 Working Group 10: Digital healthcare Breakout
07:00 - 14:00 Working Group 02: Research integrity in science Breakout
07:00 - 14:00 Working Group 04: Aviation and the environment Breakout
07:00 - 14:00 Working Group 08: Climate change – The future of transport Breakout
07:00 - 16:00 Junior Alpbach – Science and technology for young people Breakout
08:00 - 13:00 Special Event: From the Stability Pact for South Eastern Europe to the Regional Cooperation Council – A New Momentum for the Western Balkans’ Perspective in Higher Education and Research? Breakout
08:00 - 14:00 Working Group 11: Energy efficiency – Recognizing opportunities, utilizing potentials Breakout
14:30 - 15:15 The frontiers of science, part I Plenary
15:15 - 16:30 Global competition for global talents Plenary
18:00 - 19:30 Information and communications infrastructures – The nerve centres of modern societies Plenary

23.08.2008

08:00 - 08:30 Science education for a science-driven society Plenary
08:30 - 09:15 The frontiers of science, part II Plenary
09:15 - 09:45 The future of the environment and agriculture Plenary
10:00 - 10:15 Junior Alpbach and Ö1 Children’s University Alpbach 2008 Plenary
10:15 - 11:15 Improbable Research and the Ig Nobel prize Plenary
11:15 - 12:00 Snack reception, hosted by AVL List GmbH Social